Finance

Lists
TCF:LON
TheraCryf PLC
GBX 0.18
+1.33%
(+0.0024) 1D
Oct 20, 3:50:00 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for TCF...
Mkt. cap
4.92M
Avg. vol.
3.40M
Volume
0.00
52-wk high
GBX 104.70
52-wk low
GBX 95.00
Shares outstanding
2.73B
No. of employees
9
Mkt. cap
4.92M
Avg. vol.
3.40M
Volume
0.00
52-wk high
GBX 104.70
52-wk low
GBX 95.00
Shares outstanding
2.73B
No. of employees
9
News stories
From web sources and news partners
About TheraCryf PLC
CEO-
Employees9
Founded2014
Headquarters-
SectorBiotechnology
Websitetheracryf.com
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
685.50K
685.50K
1.16M
1.16M
Cost of revenue
685.50K
685.50K
1.16M
1.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
4.00K
4.00K
Operating expense
-
-
4.00K
4.00K
Total operating expenses
685.50K
685.50K
1.16M
1.16M
Operating income
-685.50K
-685.50K
-1.16M
-1.16M
Other non operating income
-
-
9.50K
9.50K
EBT including unusual items
-656.50K
-656.50K
-1.13M
-1.13M
EBT excluding unusual items
-656.50K
-656.50K
-1.13M
-1.13M
Income tax expense
-
-
-18.50K
-18.50K
Effective tax rate
-
-
1.64%
1.64%
Other operating expenses
-
-
-
-
Net income
-656.50K
-656.50K
-1.11M
-1.11M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
29.00K
29.00K
25.00K
25.00K
Interest expense
-
-
-
-
Net interest expenses
29.00K
29.00K
25.00K
25.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-683.50K
-683.50K
-1.16M
-1.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps